All AbMole products are for research use only, cannot be used for human consumption.
Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties. Many biological effects of melatonin are produced through activation of melatonin receptors, while others are due to its role as a pervasive and powerful antioxidant, with a particular role in the protection of nuclear and mitochondrial DNA.
| Molecular Weight | 232.28 |
| Formula | C13H16N2O2 |
| CAS Number | 73-31-4 |
| Solubility (25°C) | DMSO 80 mg/mL Ethanol 10 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Sankha Bhattacharya, et al. Melatonin and its ubiquitous anticancer effects
[2] Susanna Esposito, et al. Pediatric sleep disturbances and treatment with melatonin
[3] Fernanda Gaspar do Amaral, et al. A brief review about melatonin, a pineal hormone
[4] B Claustrat, et al. Melatonin: Physiological effects in humans
[5] Armando L Morera-Fumero, et al. Role of melatonin in schizophrenia
| Related Melatonin Receptor Products |
|---|
| Agomelatine
Agomelatine is a metabolically stable analog of melatonin that displays agonist activity for MT1 and MT2 binding with nanomolar affinity. Agomelatine is also a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively. |
| Ramelteon (TAK-375)
Ramelteon (TAK-375) is a novel melatonin receptor agonist for human MT1 and MT2 receptors and chick forebrain melatonin receptors with Ki of 14 pM, 112 pM and 23.1 pM, respectively. |
| 2-Phenylmelatonin
2-Phenylmelatonin is a potent melatonin agonist. |
| Luzindole
Luzindole (N-0774) is a selective competitive melatonin MT1/MT2 antagonist with Ki values of 10.2 and 158 nM for human MT2 and MT1, respectively. |
| Tasimelteon
Tasimelteon (BMS-214778) is a Dual Melatonin Receptor Agonist (DMRA) recently approved (Hetlioz) for the treatment of Non-24-hour sleep–wake disorder, a disorder primarily found in the totally blind, where a lack of normal synchronization between the 24-hour light–dark cycle and the endogenous circadian rhythm causes it to drift out of alignment with conventional sleep–wake schedules. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
